The federal court jury in Minneapolis also awarded $700,000 in compensatory damages to the man, John Schedin, who claimed he ruptured both of his Achilles tendons after he took Levaquin. Schedin argued that companies did not properly warn patients or doctors about the risk of tendon damage associated with Levaquin, the news source said.
READ MORE LEVAQUIN LEGAL NEWS
"We talked a lot about the responsibility the company had to the general public, as far as safety goes," Zach Rawson, a juror from Rochester, Minnesota, said after the trial. "We felt that they didn't warn adequately, that they didn't use enough means of warning the public, especially the doctors."
According to the National Center for Biotechnology Information, the use of Levaquin increases the risk of patients developing tendinitis or tendon rupture "during your treatment or for up to several months afterward."